Gyroscope Therapeutics lands $148m Series C

Gyroscope Therapeutics, a gene therapy company, has raised $148 million in Series C financing.

Gyroscope Therapeutics, a gene therapy company, has raised $148 million in Series C financing. Forbion led the round with participation from other investors that included Sofinnova Investments, T. Rowe Price Associates, Inc., Tetragon Financial Group Limited, Fosun Pharma, Cambridge Innovation Capital and Syncona.

Source: Press Release